A detailed history of Harbor Capital Advisors, Inc. transactions in Natera, Inc. stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 4,305 shares of NTRA stock, worth $485,345. This represents 0.05% of its overall portfolio holdings.

Number of Shares
4,305
Holding current value
$485,345
% of portfolio
0.05%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$59.21 - $92.9 $254,899 - $399,934
4,305 New
4,305 $394,000
Q2 2023

Jul 11, 2023

BUY
$47.08 - $55.16 $29,377 - $34,419
624 New
624 $30,000
Q4 2022

Jan 20, 2023

BUY
$34.17 - $47.91 $18,827 - $26,398
551 Added 32.82%
2,230 $0
Q3 2022

Oct 28, 2022

SELL
$36.93 - $56.68 $110,605 - $169,756
-2,995 Reduced 64.08%
1,679 $74,000
Q2 2022

Jul 26, 2022

BUY
$28.13 - $44.54 $64,136 - $101,551
2,280 Added 95.24%
4,674 $166,000
Q1 2022

Apr 28, 2022

BUY
$30.32 - $91.33 $72,586 - $218,644
2,394 New
2,394 $97,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $10.9B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Harbor Capital Advisors, Inc. Portfolio

Follow Harbor Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbor Capital Advisors, Inc. with notifications on news.